What this marker measures
Non-HDL cholesterol is often preferred over LDL alone when triglycerides are raised (above ~200 mg/dL), because it counts the particles LDL-C tends to miss — VLDL and remnants. ApoB measures the same idea from a particle-count angle: many guidelines now use either non-HDL or ApoB as a secondary cardiovascular target. Non-HDL can be calculated from any fasting or non-fasting standard lipid panel without extra testing.
High or low: what it can mean
High Non-HDL Cholesterol
A high non-HDL can be associated with a larger overall burden of cholesterol-carrying particles, particularly useful to track when triglycerides are above 200 mg/dL and LDL alone underestimates the picture. It is a single number that bundles LDL with VLDL and remnant particles, and it is interpreted together with the rest of the lipid panel and your overall cardiovascular context.
Read full explanation →
Low Non-HDL Cholesterol
A low non-HDL is usually a favorable finding and is generally not a concern on its own. It can occasionally appear as part of a broader nutrition, absorption or illness picture, especially when total cholesterol is also low. Reference ranges vary by lab, and one value is interpreted alongside LDL, HDL, triglycerides and the rest of the panel.
Read full explanation →
Lifestyle considerations
- •Compare non-HDL with LDL, HDL and triglycerides on the same panel — the pattern matters more than any single number
- •If triglycerides are above 200 mg/dL, non-HDL is often a more reliable risk picture than LDL alone
- •Where available, ApoB gives a complementary particle-count view alongside non-HDL
Frequently asked questions
What is Non-HDL Cholesterol?
+
Non-HDL cholesterol is calculated as total cholesterol minus HDL. It captures all cholesterol carried by particles that can contribute to plaque buildup — LDL, VLDL and remnants — and is most informative when read alongside LDL, HDL, triglycerides and (if available) ApoB.
What does Non-HDL Cholesterol measure?
+
Non-HDL cholesterol is often preferred over LDL alone when triglycerides are raised (above ~200 mg/dL), because it counts the particles LDL-C tends to miss — VLDL and remnants. ApoB measures the same idea from a particle-count angle: many guidelines now use either non-HDL or ApoB as a secondary cardiovascular target. Non-HDL can be calculated from any fasting or non-fasting standard lipid panel without extra testing.
What does high Non-HDL Cholesterol mean?
+
A high non-HDL can be associated with a larger overall burden of cholesterol-carrying particles, particularly useful to track when triglycerides are above 200 mg/dL and LDL alone underestimates the picture. It is a single number that bundles LDL with VLDL and remnant particles, and it is interpreted together with the rest of the lipid panel and your overall cardiovascular context.
What does low Non-HDL Cholesterol mean?
+
A low non-HDL is usually a favorable finding and is generally not a concern on its own. It can occasionally appear as part of a broader nutrition, absorption or illness picture, especially when total cholesterol is also low. Reference ranges vary by lab, and one value is interpreted alongside LDL, HDL, triglycerides and the rest of the panel.
What supports healthy Non-HDL Cholesterol levels?
+
Compare non-HDL with LDL, HDL and triglycerides on the same panel — the pattern matters more than any single number. If triglycerides are above 200 mg/dL, non-HDL is often a more reliable risk picture than LDL alone. Where available, ApoB gives a complementary particle-count view alongside non-HDL
Related biomarkers
Editorial note
LabTestly explains lab markers using plain-English educational content. Reference ranges may vary by laboratory and should be interpreted with a clinician.
Educational content · Editorially reviewed for clarity · Last updated
Common sources used for lab-test education
Not medical advice
This page is for general understanding only and does not replace medical advice from your clinician. Reference ranges can vary by laboratory, age, sex, pregnancy status, medications, and clinical context.